Allist(SH:688578) Zhong Guo Jing Ji Wang·2025-09-25 07:07Core Viewpoint - The announcement details the completion of share reduction by the employee stock ownership platforms of Shanghai Aixiang and Nantong Aiyun, resulting in a total cash-out of 1.445 billion yuan from the sale of 13.5 million shares, which represents 3% of the company's total share capital [1]. Group 1: Share Reduction Details - Shanghai Aixiang held 32,930,660 shares (7.32% of total shares) and Nantong Aiyun held 9,770,362 shares (2.17% of total shares) prior to the reduction [1]. - The reduction period for both platforms was from September 1, 2025, to September 24, 2025 [2][4]. - Shanghai Aixiang reduced 10,410,000 shares, with a total amount of 1.114 billion yuan, while Nantong Aiyun reduced 3,090,000 shares, amounting to 330 million yuan [2][4]. Group 2: Current Shareholding Status - After the reduction, Shanghai Aixiang holds 22,520,660 shares (5.00% of total shares) and Nantong Aiyun holds 6,680,362 shares (1.48% of total shares) [2][4]. - The original plan for Shanghai Aixiang was to reduce no more than 2.31% of its shares, while Nantong Aiyun aimed for a maximum reduction of 0.69% [2][4]. Group 3: Company Background - Ailisi was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 2, 2020, with an issuance of 90 million shares at a price of 22.73 yuan per share [5]. - The total funds raised amounted to 2.0457 billion yuan, with a net amount of 1.9325 billion yuan after deducting issuance costs [5]. - The funds were intended for various projects, including new drug research and development, headquarters and research base construction, marketing network development, and information technology projects [5].